North America Immunohistochemistry Market Dynamics and Trends by 2028

Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028

North America Immunohistochemistry Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Diagnostics and Drug Testing), Product (Antibodies, Equipment, Reagents, and Kits), and End User (Hospitals and Diagnostic Laboratories, Research Institutes, and Others)

Report Date : Nov 2021
Report Code : TIPRE00025750

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 150

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The North America immunohistochemistry market is expected to grow from US$ 838.05 million in 2021 to US$ 1,405.86 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028.

The US, Canada, and Mexico are economies in North America. Growing incidences of chronic and infectious diseases is expected to escalate the market growth. Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibody for tissue determination and distribution of antigens of particular disease. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases. Diabetes is prevailing at a high rate in the geriatric population across the region. The prevalence of diabetes is more in overweight and obese people. The obesity rates have been increasing rapidly in developed as well as developing economies across the region. Factors such as unhealthy lifestyle and sedentary life are among the major for the rise in the number of obese individuals. Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality across the region. Furthermore, there has been a rise in cancer incidence and mortality rates all over the region, making cancer the leading cause of death. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the North America region.

Countries in North America, especially the US, are highly affected due to the COVID-19 outbreak. Various healthcare research centers across the country are focused on COVID-19 treatments. The outbreak pandemic has adversely affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increasing demand for invitro diagnostic products and rising research and development activities in North America. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out amid the outbreak and delayed or prolonged procurement of equipment. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches are expected to pave the way for entirely virtual trials in the future. New technologies, such as mRNA, are expected to drive the pharmaceutical industry. Thus, the market is expected to witness vertical integration and joint ventures in coming years.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America immunohistochemistry market. The North America immunohistochemistry market is expected to grow at a good CAGR during the forecast period.

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Immunohistochemistry Market Segmentation

North America Immunohistochemistry Market – By Product

Equipment
- Slide Staining Systems
- Tissue Microarray Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment
Antibodies
- Primary Antibodies
- Secondary Antibodies
Reagents
- Histological Stains
- Blocking and Fixation Reagents
- Chromogenic Substrates
- Fixation Reagents
- Stabilizers
- Organic Solvents
- Proteolytic Enzymes
- Diluents
Kits

North America Immunohistochemistry Market – By Application

Diagnostics
- Cancer
- Infectious Diseases
- Autoimmune Diseases
- Diabetes Mellitus
- Nephrological Diseases
- Others
Drug Testing

North America Immunohistochemistry Market – By End User

Hospitals and Diagnostic Laboratories
Research Institutes
Others

North America Immunohistochemistry Market, by Country

US
Canada
Mexico

North America Immunohistochemistry Market - Companies Mentioned

Abcam plc
Agilent Technologies, Inc.
Bio SB
BIO-RAD LABORATORIES INC.
Cell Signaling Technology, Inc.
Danaher
F. HOFFMANN-LA ROCHE LTD.
MERCK KGaA
PerkinElmer Inc.
THERMO FISHER SCIENTIFIC INC.

North America Immunohistochemistry Report Scope

Report Attribute	Details
Market size in 2021	US$ 838.05 Million
Market Size by 2028	US$ 1,405.86 Million
Global CAGR (2021 - 2028)	7.7%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Application Diagnostics and Drug Testing By Product Antibodies Equipment Reagents Kits By End User Hospitals and Diagnostic Laboratories Research Institutes
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Abcam plc Agilent Technologies, Inc. Bio SB BIO-RAD LABORATORIES INC. Cell Signaling Technology, Inc. Danaher F. HOFFMANN-LA ROCHE LTD. MERCK KGaA PerkinElmer Inc.

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Immunohistochemistry Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

North America Immunohistochemistry Market Report Snapshots

Our Top Trending Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, Market Research

The research report delivered details on drivers and restraints, trends, and opportunities, along with strategic activities in the market. Previously, we were struggling to get reliable information.

Manager Medical Devices Manufacturing

Reason to Buy

Informed Decision-Making
Understanding Market Dynamics
Competitive Analysis
Identifying Emerging Markets

Customer Insights
Market Forecasts
Risk Mitigation
Boosting Operational Efficiency

Strategic Planning
Investment Justification
Tracking Industry Innovations
Aligning with Regulatory Trends

Your Key Concerns Addressed - Question & Answer

Can I view a sample of the report before purchasing?

Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

Is analyst support included with the purchase?

Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

What are the next steps once I place an order?

Once your order is successfully placed, you will receive a confirmation email along with your invoice.

• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

Can the report be tailored to suit my specific needs?

We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

In what format is the report delivered?

The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

How secure is the payment process on your platform?

Our payment process is fully secure and PCI-DSS compliant.

We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.

Do you provide special pricing for buying multiple reports?

Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

Can I connect with your team to discuss the report before buying?

Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

Will I get a billing invoice upon purchase?

Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

Is there support available if I can’t access my report?

Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

Buy Now

87-673-9708

ISO 9001:2015